HUP9701316A3 - Substituted indanylideneacetylguanidines, process for their preparation, and medicaments and diagnostics containing them - Google Patents

Substituted indanylideneacetylguanidines, process for their preparation, and medicaments and diagnostics containing them

Info

Publication number
HUP9701316A3
HUP9701316A3 HU9701316A HUP9701316A HUP9701316A3 HU P9701316 A3 HUP9701316 A3 HU P9701316A3 HU 9701316 A HU9701316 A HU 9701316A HU P9701316 A HUP9701316 A HU P9701316A HU P9701316 A3 HUP9701316 A3 HU P9701316A3
Authority
HU
Hungary
Prior art keywords
indanylideneacetylguanidines
medicaments
substituted
preparation
diagnostics containing
Prior art date
Application number
HU9701316A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of HU9701316D0 publication Critical patent/HU9701316D0/hu
Publication of HUP9701316A2 publication Critical patent/HUP9701316A2/hu
Publication of HUP9701316A3 publication Critical patent/HUP9701316A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C327/54—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HU9701316A 1996-07-30 1997-07-29 Substituted indanylideneacetylguanidines, process for their preparation, and medicaments and diagnostics containing them HUP9701316A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96112275A EP0837055A1 (en) 1996-07-30 1996-07-30 Substituted Indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them

Publications (3)

Publication Number Publication Date
HU9701316D0 HU9701316D0 (en) 1997-09-29
HUP9701316A2 HUP9701316A2 (hu) 1998-03-02
HUP9701316A3 true HUP9701316A3 (en) 1998-07-28

Family

ID=8223055

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9701316A HUP9701316A3 (en) 1996-07-30 1997-07-29 Substituted indanylideneacetylguanidines, process for their preparation, and medicaments and diagnostics containing them

Country Status (29)

Country Link
US (1) US5900436A (hu)
EP (2) EP0837055A1 (hu)
JP (1) JP4039589B2 (hu)
KR (1) KR980009236A (hu)
CN (1) CN1064351C (hu)
AR (1) AR008095A1 (hu)
AT (1) ATE207888T1 (hu)
AU (1) AU715187B2 (hu)
BR (1) BR9704131A (hu)
CA (1) CA2211982C (hu)
CZ (1) CZ241197A3 (hu)
DE (1) DE69707777T2 (hu)
DK (1) DK0822182T3 (hu)
ES (1) ES2164283T3 (hu)
HR (1) HRP970424B1 (hu)
HU (1) HUP9701316A3 (hu)
ID (1) ID17565A (hu)
IL (1) IL121407A0 (hu)
MX (1) MX9705737A (hu)
NO (1) NO308213B1 (hu)
NZ (1) NZ328440A (hu)
PL (1) PL321392A1 (hu)
PT (1) PT822182E (hu)
RU (1) RU2176638C2 (hu)
SI (1) SI0822182T1 (hu)
SK (1) SK282128B6 (hu)
TR (1) TR199700704A2 (hu)
TW (1) TW445251B (hu)
ZA (1) ZA976735B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ES2657938T3 (es) 2008-12-31 2018-03-07 Ardelyx, Inc. Compuestos y métodos para inhibir el antipuerto mediado por NHE en el tratamiento de trastornos asociados a la retención de líquidos o a la sobrecarga de sales y trastornos del tracto gastrointestinal
GB0916163D0 (en) * 2009-09-15 2009-10-28 Shire Llc Prodrugs of guanfacine
EP2983667B1 (en) 2013-04-12 2019-03-20 Ardelyx, Inc. Nhe3-binding compounds and methods for inhibiting phosphate transport
MA47203A (fr) 2017-01-09 2019-11-13 Ardelyx Inc Inhibiteurs d'antiport à médiation par nhe
MX2019008170A (es) 2017-01-09 2020-02-07 Ardelyx Inc Compuestos útiles para tratar transtornos del tracto gastrointestinal.
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DE4421536A1 (de) * 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
ID17565A (id) 1998-01-08
US5900436A (en) 1999-05-04
DE69707777T2 (de) 2003-01-16
EP0822182B1 (en) 2001-10-31
ATE207888T1 (de) 2001-11-15
RU2176638C2 (ru) 2001-12-10
JPH1129545A (ja) 1999-02-02
DE69707777D1 (de) 2001-12-06
ES2164283T3 (es) 2002-02-16
BR9704131A (pt) 1998-12-29
NO308213B1 (no) 2000-08-14
CZ241197A3 (cs) 1998-02-18
PL321392A1 (en) 1998-02-02
SK282128B6 (sk) 2001-11-06
JP4039589B2 (ja) 2008-01-30
PT822182E (pt) 2002-03-28
AU3155497A (en) 1998-02-05
AR008095A1 (es) 1999-12-09
CN1172104A (zh) 1998-02-04
HUP9701316A2 (hu) 1998-03-02
MX9705737A (es) 1998-02-28
HU9701316D0 (en) 1997-09-29
NZ328440A (en) 1997-11-24
TR199700704A2 (xx) 1998-02-21
EP0837055A1 (en) 1998-04-22
HRP970424B1 (en) 2002-06-30
HRP970424A2 (en) 1998-06-30
EP0822182A1 (en) 1998-02-04
IL121407A0 (en) 1998-01-04
SK103497A3 (en) 1998-02-04
KR980009236A (ko) 1998-04-30
CA2211982C (en) 2007-09-18
CA2211982A1 (en) 1998-01-30
TW445251B (en) 2001-07-11
DK0822182T3 (da) 2002-02-25
NO973486D0 (no) 1997-07-29
AU715187B2 (en) 2000-01-20
SI0822182T1 (en) 2002-04-30
ZA976735B (en) 1998-01-30
CN1064351C (zh) 2001-04-11
NO973486L (no) 1998-02-02

Similar Documents

Publication Publication Date Title
SI0676409T1 (en) Erythromycin derivatives, their process for preparation and their application as medicaments
HUP0001115A3 (en) Heterocyclylmethyl-substituted pyrazol derivatives, process for their preparation and pharmaceuticals containing the same
HUP9603495A2 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
IL128601A0 (en) 7alpha-(epsilon-aminoalkyl) estratrienes, process for preparing the same, pharmaceutical preparation containing said 7alpha-(epsilon-aminoalkyl) estratrienes and their use for preparing medicaments
HUP9601529A3 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9603433A2 (en) 4-6-diaryl-pyrimidine-derivatives, process for producing them and pharmaceutical compositions containing them
HUP0100684A3 (en) Substituted chroman derivatives, process for their preparation and medicaments containing them
HUP9701270A3 (en) Neuraminic acid derivatives, medicaments containing them and their use for producing medicaments
HUP0100927A3 (en) Antitumor substituted indene-derivatives, process for their preparation, medicaments containing them and their use
HUP0100276A3 (en) Substituted chroman derivatives, process for their preparation and medicaments containing them
HK1010885A1 (en) 10,13,15-trioxatricyclo [9.2.1.1.9.6]-pentadecanone-derivatives, process for their preparation and pharmaceutical containing them
GR3032221T3 (en) Basically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics as well as medicaments containing them
HUP9903902A3 (en) Bromotiacumicin compounds, process for producing them and medicaments containing the same
ZA988285B (en) 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles process for their preparation and their use for medicaments
HUP0104620A3 (en) 2-phenylpyran-4-one derivatives, process for their preparation and medicaments containing them
HU9503801D0 (en) Substituted 4-phenyl-thiazol derviatives, process for producing them and pharmaceutical compositions containing them
HUT75112A (en) Oxathiolanes, method for their preparation and pharmaceutical compositions contating same
HUP9903632A3 (en) Neuraminic acid compounds, medicaments containing the same and method for producing the same medicaments
HUP9600665A3 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
HUP9701316A3 (en) Substituted indanylideneacetylguanidines, process for their preparation, and medicaments and diagnostics containing them
HUP9700989A3 (en) Ortho-substituted benzoyl-guanidines, process for producing them, and pharmaceutical compositions containing them
HUP9601331A3 (en) Piperazine- and homopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them
HU9503318D0 (en) Arthropocidal compounds, compositions containing them and process for their preparation
HUP9702227A3 (en) New benzopirane compounds, process for producing them and pharmaceutical composition containing them
HUT73975A (en) Substituted benzol-sulfonyl-ureas and-thioureas, process for producing them, pharmaceutical compositions containing them and their use